Global Human Embryonic Stem Cells Market: Regional Insights
Based on geography, the global human embryonic stem cells market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Among regions, North America is expected to gain highest share in the market over the forecast period owing to the high prevalence of cardiac and malignant diseases and increase in focus in the development of cell line based therapies in this region, especially in the U.S. For instance, human embryonic stem cells (hESC) have a high potential for use in treatment and may become a standard of care for these diseases. Heart disease is one of the leading cause of death in the United States. According to the Centers for Disease Control and Prevention (CCD), one person dies every 34 seconds from heart disease in the U.S.
Asia Pacific is also expected to witness significant growth in the global human embryonic stem cells market owing to the rising burden of chronic diseases and government support for hESC research in the region. For instance, in February 2020, the Global Institute of Stem Cell Therapy and Research (GIOSTAR) inaugurated a new stem cell and cancer research and therapy centre in India. This facility represents the latest milestone in global expansion efforts spearheaded by GIOSTAR in India, Mexico, the United States, and numerous other countries. It is the most recent in a series of hospitals being launched throughout the country.
Human Embryonic Stem Cells Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients